AIM ImmunoTech shareholders approve stock issuance proposals at special meeting
AIM•Special meeting results
AIM ImmunoTech held a special shareholder meeting on July 15, 2026.
- Shareholders authorized issuing more than 19.99% of outstanding common stock tied to exercises of Class H warrants; the measure passed.
- A similar authorization for potential issuance upon exercise of Class I warrants was also adopted.
- Shareholders also adopted the authorization for potential issuance upon exercise of Class J warrants.
